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Abstract
Background: Previous studies have shown that total cholesterol (TC) levels are associated with stroke outcomes,
but sex differences in the association between TC levels, especially a low TC level, and ischemic stroke outcomes
are unknown. We aimed to assess the sex differences in stroke outcomes among patients with atherothrombotic
infarctions and low TC levels in China.
Methods: This study recruited patients with atherothrombotic infarctions from Tianjin, China, between May 2005
and September 2014. Patients with low TC levels (defined as TC <4.22 mmol/L) were analyzed in this study. Sex
differences in stroke subtypes, severity, risk factors, and outcomes at 3 and 12 months after stroke were compared.
Results: Overall, 1587 patients with low TC levels were recruited to this study from among 6407 patients with
atherothrombotic infarctions listed in a stroke registry. Women were more likely than men to have posterior circulation
infarcts, severe stroke, hypertension, and obesity but less likely to be current smokers or to consume alcohol. There
were no sex differences in stroke outcomes. Older age and severe stroke were common risk factors for poor outcomes
after stroke in this study. The presence of diabetes mellitus was an independent predictor of low mortality at
12 months after stroke, possibly because a drug commonly used to treat diabetes, metformin, enhances angiogenesis.
Obesity was the determinant of the recurrence and dependency rates at 12 months after stroke.
Conclusions: These findings suggest that patients (both men and women) with atherothrombotic infarction who have
low TC levels would not benefit from receiving statin treatment. Therefore, it is crucial to explore the impact of statin
treatment on outcomes in Asian patients, especially Chinese patients with atherothrombotic and low TC levels, in order
to improve outcomes after stroke and reduce the disease burden.
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Background
Although age-standardized rates of stroke mortality have
decreased worldwide in the past few decades, the global
burden of stroke disability-adjusted life-years is a crucial
health issue due to the increasing absolute number of
stroke survivors [1, 2]. In 2014, in China, stroke was the
third most common cause of death overall, the third in
urban areas, and the second in rural areas [3]. Moreover,
stroke is also a leading cause of functional impairments,
with 20% of survivors requiring institutional care after
3 months and 15–30% being permanently disabled [4].
High total cholesterol (TC) level is a well-documented
risk factor for coronary disease [5, 6]. Moreover, hyperchol-
esterolemia has been well-documented as a modifiable risk
factor for ischemic stroke [7], although a lower TC level
was shown to be an independent predictor of hemorrhagic
stroke in previous studies [8, 9]. The association between
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TC levels and stroke outcomes is controversial. A large
number of studies have indicated that high TC levels were
associated with better stroke outcomes [7, 10, 11], but the
reverse trend was observed in other studies [12, 13].
With recent economic development, the incidence of
stroke in China has increased dramatically [14]; however,
large-scale studies of the association between TC level
and stroke outcomes in China are rare, especially in pa-
tients with atherothrombotic infarction.
Therefore, we aimed to assess the sex differences in the
associations between low TC levels on admission and long-
term stroke outcomes after acute ischemic stroke (AIS) in
patients with atherothrombotic infarction in China.
Methods
Patients
This was a hospital-based follow-up study using the Stroke
Registry System that we developed in 2005 in Tianjin
Huanhu Hospital, a specialized neurological hospital in
Tianjin, China. All consecutive patients with first-ever AIS
who were admitted to the Stroke Unit at Tianjin Huanhu
Hospital within 72 h of stroke onset between May 2005
and September 2014 were recruited to this study. A clinical
diagnosis of stroke was made according to the World
Health Organization criteria and confirmed by neuroimag-
ing (computed tomography/magnetic resonance imaging)
[15]. Cases of transient ischemic attack were excluded from
this study. The study originally included all patients with
atherothrombotic infarction classified according to the Trial
of Org 10172 in Acute Stroke Treatment (TOAST) for
large-artery atherothrombosis and small-artery occlusion
(SAO) [16], who were treated using statins and for whom
data on TC level on admission were available. The patients
were further categorized into two groups according to TC
level on admission: the low-TC group, defined as patients
with a TC level <4.22 mmol/L, and the non-low-TC group,
defined as patients with a TC level ≥4.22 mmol/L. For this
study, the final study population included only patients with
low TC.
Ethics, consent, and permissions
The study was approved by the Ethics Committee for
Medical Research at Tianjin Huanhu Hospital, and writ-
ten informed consent was obtained from each partici-
pant during recruitment.
Data collection and group assignments
Detailed information on ischemic stroke subtype, stroke
severity, previous history of diseases, stroke risk factors,
laboratory examination results, and outcomes at 3 and
12 months after stroke were obtained from a standard-
ized questionnaire and recorded in the Stroke Registry
System.
To ensure data quality, three groups of senior trained
neurologists (the assessment group, the follow-up group,
and the quality control group) were responsible for deter-
mining the nervous system score at admission, for the reex-
amination (including of neurological score, risk factor
management, and directing the treatment and rehabilita-
tion) during follow-up, and for a sampled confirmation of
20% of all patients each month, respectively.
Stroke subtypes
Stroke subtypes were defined as total anterior circulation
infarct (TACI), partial anterior circulation infarct (PACI),
posterior circulation infarct (POCI), and lacunar infarct
(LACI) according to the Oxfordshire Community Stroke
Project (OCSP) classification criteria [17].
Neurological function deficits and stroke severity
Neurological function deficits were defined using the
National Institutes of Health stroke scale (NIHSS),
Barthel index (BI) [18], and modified Rankin scale
(mRS) on admission [19]. Stroke severity was catego-
rized into three groups on the basis of the NIHSS score:
mild (NIHSS ≤7), moderate (NIHSS between 8 and 16),
and severe (NIHSS ≥17) [20].
Risk factors
Stroke risk factors included a medical history of hyperten-
sion (defined as a self-reported history of hypertension or
the use of antihypertension drugs), diabetes mellitus (DM,
defined as a history of DM or the use of hypoglycemic
medications at discharge), atrial fibrillation (AF, defined as a
history of AF, confirmed by at least one electrocardiogram,
or the presence of arrhythmia during hospitalization), and
obesity (body mass index ≥30 kg/m2) and modifiable life-
style factors, including current smoking status and alcohol
consumption.
Definitions of outcomes
Stroke outcomes were described on the basis of mortal-
ity, recurrence, and dependency rates at 3 and 12 months
after stroke. Outcomes were assessed using face-to-face
or telephone follow-up interviews. Death was defined as
all-cause cumulative death at the corresponding follow-
up time points after stroke, and this information was
collected from medical records or patients’ family mem-
bers by telephone follow-up. Recurrence was defined as
new-onset vascular events (stroke, myocardial infarction,
and venous thrombosis) 30 days after the initial stroke
in all survivors who completed follow-up using face-to-
face interviews or telephone calls. Dependency was de-
fined as an mRS score >2 among all survivors who
underwent follow-up using face-to-face interview or
telephone calls [21].
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Follow-up period
Follow-up was conducted according to a predetermined
procedure. Trained neurologists reexamined patients in
the outpatient department at 3 and 12 months after
stroke. All patients completed follow-up by face-to-face
interview, except for patients who were reexamined in
their neighboring hospitals; these patients completed
follow-up by telephone.
Statistical analysis
Age is presented as mean (standard deviation), and NIHSS,
BI, and mRS scores are presented as medians (interquartile
ranges). These continuous variables were compared be-
tween men and women using the Student t test or the
Mann-Whitney U test, as appropriate. At the different
follow-up time periods after stroke, categorical variables,
including stroke subtype, stroke severity, risk factors, and
outcomes, are presented as number (percentage), and the
trends were compared using chi-squared tests. Associations
between the relevant risk factors and outcomes in men and
women were assessed individually using univariate and
multivariate logistic regression models and are presented as
unadjusted and adjusted (by age, stroke severity, stroke sub-
types, and risk factors) odds ratios (ORs), respectively, with
95% confidence intervals (CIs). All statistical analyses were
performed using SPSS version 15.0 (SPSS Inc., Chicago, IL),




Of the 7565 AIS patients recruited between May 2005
and September 2014, 392 patients with cardioembolic
stroke, 284 patients with other stroke and stroke of un-
determined causes, and 482 patients without a TC level
recorded on admission were excluded, resulting in 6407
patients with atherothrombotic infarction that were in-
cluded. Of these, there were 1587 patients with low TC
levels. After excluding those patients who did not
complete follow-up, the response rate was 97.4% at
3 months and 94.9% at 12 months (Fig. 1).
Sex differences in clinical features among patients with
atherothrombotic infarction
Of the 1578 patients with low TC levels, 1272 (80.2%) were
men and 315 (19.8%) were women. Women were more
likely than men to have PACI (33.0 vs. 31.5%, P = 0.006),
hypertension (80.6 vs. 71.4%, P < 0.001), and obesity (18.1
vs. 7.9%, P < 0.001), but men were more likely than women
to have mild stroke (69.9 vs. 64.8%, P < 0.001), to be current
smokers (49.4 vs. 13.0%, P < 0.001), or to drink alcohol
Fig. 1 Flow diagram of participants
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(26.3 vs. 1.3%, P < 0.001). Moreover, women showed poorer
neurological function (Table 1).
Sex differences in outcomes among patients with
atherothrombotic infarction and low TC levels
Table 2 shows that women had significantly higher recur-
rence and dependency rates at 12 months than men did;
the corresponding rates were 33.2 vs. 25.1% (P = 0.010) for
recurrence rate at 12 months and 31.3 vs. 24.5% (P = 0.031)
for dependency rate at 12 months. However, there were no
significant differences in mortality at 3 and 12 months after
stroke or in recurrence and dependency rates at 3 months
after stroke.
Sex differences in risk factors for outcomes at 3 and
12 months after stroke among patients with
atherothrombotic infarction and low TC levels
Results of the univariate analysis indicated that age and
stroke severity were significantly associated with outcomes
at 3 and 12 months after stroke. Moreover, OCSP classifica-
tion, diabetes mellitus (DM), arterial stenosis, and alcohol
drinking were associated with mortality, and sex, obesity,
and current smoking were associated with recurrence and
dependency rates (Table 3).
The sex differences in recurrence and dependency rates
became non-significant after adjustment for age, severity,
subtype, and risk factors. Older age and stroke severity were
independent risk factors for stroke outcomes. A low risk of
mortality was observed in patients with DM at 12 months
after stroke, but a positive association was found between
obesity and the recurrence and dependency rates at
12 months after stroke. The risk of mortality decreased by
49% at 12 months in patients with DM (P = 0.013). How-
ever, the risk increased by 77% for recurrence (P = 0.008)
and by 87% for dependency (P = 0.004) at 12 months in
patients with obesity (Table 4).
Discussion
This is the first report to demonstrate sex differences in
clinical features, risk factors, and outcomes among patients
with atherothrombotic infarction and low TC levels.
Women were more likely than men to have PACI, poor
neurological function, hypertension, and obesity, but men
were more likely than women to be current smokers or to
drink alcohol. There were significantly higher recurrence
and dependency rates at 12 months in women than in men.
However, the sex differences in stroke outcomes disap-
peared after adjustment for age, stroke severity, subtype,
and risk factors.
Previous studies have indicated that women tend to have
strokes at an older age than men do [22–24]. It has been
reported that women were more likely than men to have
severe stroke [23, 25], but this result was not found in other
studies [26, 27]. Moreover, a greater prevalence of
hypertension, DM, atrial fibrillation, dyslipidemia, and
obesity has been reported for women in previous studies
[20, 28, 29]. Consistent with these studies, in the present
study, we found that women were more likely than men to
have POCI, severe stroke, hypertension, and obesity but less
Table 1 Sex differences in clinical characteristics and risk factors
among patients with low TC level and atherosclerotic stroke
Characteristics Total Men Women P
Cases, n (%) 1587 1272 (29.5) 315 (15.1) –
Age, year, mean (SD) 64.41 (11.40) 64.17 (11.42) 65.40 (11.28) 0.087
OCSP, n (%)
PACI 895 (56.4) 728 (57.2) 167 (53.0) 0.177
TACI 83 (5.2) 62 (4.9) 21 (6.7) 0.201
LACI 104 (6.6) 81 (6.4) 23 (7.3) 0.549
POCI 505 (31.8) 401 (31.5) 104 (33.0) 0.006
Stroke severity
Mild 1093 (68.9) 889 (69.9) 204 (64.8) <0.001
Moderate 367 (23.1) 289 (22.7) 78 (24.8) 0.442
Severe 127 (8.0) 94 (7.4) 33 (10.5) 0.071
Neurological functiona
NIHSS 5 (7) 5 (7) 6 (7) 0.006
BI 60 (50) 65 (50) 55 (50) 0.004
mRS 3 (2) 3 (2) 3 (2) 0.007
Risk factors, n (%)
Hypertension 1162 (73.2) 908 (71.4) 254 (80.6) 0.001
Diabetes 472 (29.7) 366 (28.8) 106 (33.7) 0.090
Atrial fibrillation 71 (4.5) 52 (4.1) 19 (6.0) 0.135
Artery stenosis 416 (26.2) 341 (26.8) 75 (23.8) 0.279
Obesity 157 (9.9) 100 (7.9) 57 (18.1) <0.001
Current smoking 669 (42.2) 628 (49.4) 41 (13.0) <0.001
Alcohol drinking 339 (21.4) 335 (26.3) 4 (1.3) <0.001
OCSP Oxfordshire Community Stroke Project, TACI total anterior circulation
infarct, PACI partial anterior circulation infarct, POCI posterior circulation infarct,
LACI lacunar infarct, NIHSS National Institute of Health stroke scale, BI Barthel
index, mRS modified Rankin scale
aData were presented as median with interquartile range
Table 2 Sex differences in outcomes among atherosclerotic
stroke patients with low TC level
Outcomes Men Women P
At 3 months after stroke
Mortality, n (%) 63 (6.3) 13 (5.7) 0.736
Recurrence, n (%) 94 (10.0) 24 (11.1) 0.630
Dependency, n (%) 99 (10.5) 25 (11.6) 0.659
At 12 months after stroke
Mortality, n (%) 95 (8.8) 23 (8.6) 0.945
Recurrence, n (%) 253 (25.1) 83 (33.2) 0.010
Dependency, n (%) 242 (24.5) 76 (31.3) 0.031
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likely to be current smokers and to consume alcohol. The
delayed time to hospital admission in women could explain
the greater frequency of severe stroke [30].
High cholesterol level is an identified risk factor for cor-
onary heart disease, but its role in stroke remains contro-
versial. The associations between high serum TC levels and
an increased risk of ischemic stroke have been reported in
several studies [31, 32], but a clear association was not
found in others [33–37]. A positive association between TC
levels and atherothrombotic infarction has been reported in
previous studies [38, 39]. Other studies have indicated that
a higher TC level increased the risk of cerebral infarction
Table 3 Unadjusted OR with 95% CI of outcome determinants at 3 and 12 months after stroke among patients with low TC level in
univariate analysis
Factors Reference Mortality Recurrence Dependency
3 months 12 months 3 months 12 months 3 months 12 months
Men Women 0.94 (0.56, 1.60) 0.98 (0.61, 1.58) 1.02 (0.66, 1.57) 1.48 (1.10, 2.00)* 1.10 (0.73, 1.66) 1.40 (1.03, 1.91)*
Age – 1.07 (1.05, 1.10)* 1.07 (1.05, 1.10)* 1.03 (1.01, 1.05)* 1.02 (1.01, 1.04)* 1.03 (1.02, 1.05)* 1.02 (1.01, 1.04)*
OCSP POCI
PACI 0.73 (0.47, 1.15) 0.94 (0.62, 1.44) 0.97 (0.66, 1.42) 1.03 (0.78, 1.36) 1.00 (0.69, 1.46) 1.05 (0.79, 1.39)
TACI 1.91 (0.90, 4.02) 2.46 (1.21, 5.02)* 1.72 (0.84, 3.51) 1.70 (0.93, 3.09) 1.86 (0.93, 3.72) 1.65 (0.89, 3.08)
LACI 0.25 (0.06, 1.06) 0.44 (0.15, 1.25) 0.56 (0.23, 1.35) 0.74 (0.43, 1.27) 0.65 (0.28, 1.47) 0.70 (0.40, 1.22)
Stroke severity Mild
Moderate 5.02 (2.82, 8.93)* 3.80 (2.31, 6.26)* 1.88 (1.27, 2.77)* 2.32 (1.74, 3.08)* 1.85 (1.26, 2.72)* 2.31 (1.73, 3.09)*
Severe 32.18 (18.02, 57.47)* 32.44 (18.99, 55.43)* 3.74 (2.11, 6.66)* 2.44 (1.39, 4.30)* 4.43 (2.55, 7.67)* 2.15 (1.16, 4.00)*
Hypertension No 0.71 (0.46, 1.11) 0.73 (0.49, 1.08) 1.08 (0.73, 1.61) 1.24 (0.93, 1.64) 1.16 (0.78, 1.72) 1.26 (0.94, 1.69)
Diabetes No 0.57 (0.34, 0.95)* 0.56 (0.35, 0.90)* 0.95 (0.65, 1.39) 1.12 (0.85, 1.47) 0.89 (0.61, 1.29) 1.20 (0.91, 1.57)
AF No 1.24 (0.49, 3.17) 1.66 (0.73, 3.77) 0.63 (0.22, 1.75) 1.05 (0.55, 2.02) 0.59 (0.21, 1.65) 0.93 (0.46, 1.85)
Artery stenosis No 0.50 (0.29, 0.88)* 0.59 (0.36, 0.97)* 1.14 (0.78, 1.66) 1.08 (0.81, 1.42) 1.10 (0.75, 1.59) 1.09 (0.82, 1.45)
Obesity No 0.50 (0.20, 1.25) 0.45 (0.18, 1.12) 0.90 (0.49, 1.63) 1.84 (1.23, 2.76)* 0.85 (0.47, 1.54) 1.94 (1.29, 2.91)*
Current smoking No 0.79 (0.52, 1.22) 0.85 (0.58, 1.26) 0.71 (0.50, 1.02) 0.74 (0.57, 0.95)* 0.68 (0.47, 0.96)* 0.72 (0.56, 0.94)*
Alcohol drinking No 0.57 (0.32, 1.04) 0.55 (0.32, 0.94)* 0.67 (0.42, 1.07) 0.84 (0.62, 1.14) 0.60 (0.37, 0.96)* 0.84 (0.62, 1.15)
OR odds ratios, CI confidence intervals; *Presented P<0.05 in univariate analysis
Table 4 Adjusted OR with 95% CI of outcome determinants at 3 and 12 months after stroke among patients with low TC level in
multivariate analysis
Factors Reference Mortality Recurrence Dependency
3 months 12 months 3 months 12 months 3 months 12 months
Men Women – – – 1.27 (0.92, 1.75) – 1.18 (0.84, 1.64)
Age – 1.06 (1.03, 1.08)* 1.06 (1.04, 1.08)* 1.03 (1.01, 1.04)* 1.02 (1.01, 1.03)* 1.03 (1.01, 1.04)* 1.02 (1.01, 1.03)*
OCSP POCI
PACI – 0.77 (0.47, 1.25) – – – –
TACI – 0.80 (0.33, 1.99) – – – –
LACI – 0.59 (0.19, 1.86) – – – –
Stroke severity Mild
Moderate 4.86 (2.72, 8.70)* 3.77 (2.25, 6.30)* 1.86 (1.26, 2.75)* 2.27 (1.70, 3.03)* 1.84 (1.24, 2.71)* 2.28 (1.70, 3.05)*
Severe 26.23 (14.47, 47.55)* 27.46 (15.39, 49.02)* 3.39 (1.89, 6.06)* 2.27 (1.28, 4.02)* 3.92 (2.24, 6.85)* 1.96 (1.05, 3.68)*
Diabetes No – 0.51 (0.30, 0.87)* – – – –
Artery stenosis No 0.68 (0.37, 1.24) 0.73 (0.42, 1.28) – – – –
Obesity No – – – 1.77 (1.17, 2.70)* – 1.87 (1.23, 2.84)*
Current smoking No – – – 0.92 (0.70, 1.22) 0.90 (0.60, 1.35) 0.89 (0.67, 1.19)
Alcohol drinking No – 0.47 (0.42, 1.49) – – 0.76 (0.45, 1.30) –
OR odds ratios, CI confidence intervals; *Presented P<0.05 after adjusted by covariates
Zhou et al. Biology of Sex Differences  (2016) 7:62 Page 5 of 8
[9, 40], but sex differences in the association between TC
level and stroke outcomes are not well-known.
TC levels were associated with increased risk of severe
stroke, TACI, and poor functional outcomes in patients
with ischemic stroke who had received pre-stroke statin
treatment, and the short-term and long-term mortality
rates were significantly higher in patients with low chol-
esterol levels [41].
Poor outcomes after AIS have been reported in pa-
tients with low cholesterol levels [9, 40, 41]. In particu-
lar, a negative or non-significant association between TC
level and mortality was observed in patients with ische-
mic stroke aged 70 years or older [35]. Higher TC levels
were also associated with lower short-term mortality
after stroke; the neuroprotective role of cholesterol may
have contributed to this finding [11, 42, 43]. Another
study indicated that the lower mortality after stroke
among patients with higher cholesterol levels attributed
to hypercholesterolemia could be linked to minor
strokes (mainly small-vessel stroke) with good outcomes
[44]. Several large-scale studies demonstrated that lower
TC levels were associated with higher all-cause mortality
and that higher TC levels were associated with lower all-
cause mortality [45, 46]. Furthermore, a U-shaped asso-
ciation between TC level and dependency after AIS was
shown in a group of people of very old age; patients with
moderate TC levels had the most favorable outcomes
after AIS in patients aged >80 years [47]. Moreover, our
previous study indicated that low cholesterol levels
among patients with atherothrombotic infarction receiv-
ing statin treatment increased long-term dependency
and recurrence rates, but not mortality rates [48].
Consistent with the results of previous studies, in the
present study, higher recurrence and dependency rates
at 12 months after stroke were observed for women than
for men. The sex differences in recurrence and depend-
ency rates became statistically non-significant after ad-
justment for covariates. Moreover, older age and stroke
severity were independent risk factors for stroke out-
comes in this study. A low risk of mortality was ob-
served in patients with DM at 12 months after stroke,
but a positive association was found between obesity
and recurrence and dependency rates at 12 months after
stroke. The negative association between DM and mor-
tality at 12 months after stroke could be explained by
treating patients with metformin, which mediates en-
hanced angiogenesis [49].
Statin therapy has become the most important ad-
vancement in stroke prevention since aspirin and blood
pressure-lowering therapies were introduced. Clinical
trials have shown that lowering cholesterol levels can re-
duce the incidence of stroke in high-risk populations
and in patients with a stroke or transient ischemic attack
[37, 50]. However, in this study, worse long-term
dependency and recurrence rates occurred in female pa-
tients with low TC levels on admission, and all patients
received statin treatment after stroke. Thus, the benefit
of statins for improving outcomes after stroke in Asian
populations, especially in Chinese people, needs to be
explored further.
There are several limitations in this study. First, all
patients were from a local neurological hospital in
Tianjin, China, and may not represent all stroke pa-
tients in China. Second, data on statin use before
stroke onset were lacking, which may have affected
the evaluation of TC level on stroke outcomes. How-
ever, the aim of this study was to evaluate the differ-
ences in stroke outcomes between men and women
with low TC levels. Thus, it is not likely that the
lack of information regarding previous statin use had
a major impact on the results. Third, there were a
few patients who completed follow-up by telephone
(2.8% at 3 months and 12.2% at 12 months), which
may have introduced an assessment bias due to a
measurement disparity. Moreover, the differences in
baseline characteristics (higher prevalence of DM at
3 months; older age, higher frequency of severe
stroke, and higher prevalence of DM at 12 months)
may have partially affected the assessment of the as-
sociation between outcomes and risk factors. Finally,
the TC compositions were not measured in this
study, which may have affected the evaluation of
stroke outcomes among patients with a low TC level.
Conclusions
This large, hospital-based, prospective study was the
first to report sex differences in outcomes at 3 and
12 months after stroke among patients with athero-
thrombotic infarction and low TC levels. Women
were more likely than men to have POCI, severe
stroke, hypertension, and obesity and were less likely
to smoke or consume alcohol. There were no sex dif-
ferences in stroke outcomes. Older age and severe
stroke were common risk factors for poor outcomes
after stroke in this study. DM was an independent
predictor of low mortality at 12 months after stroke,
which could be explained by metformin’s mediation
of enhancing angiogenesis. Obesity was the determin-
ant of recurrence and dependency rates at 12 months
after stroke. These findings suggest that patients (both
men and women) with atherothrombotic infarction
and low TC levels would not benefit from receiving
statin treatment. Therefore, it is crucial to explore the
impact of statin treatment on outcomes in Asian pa-
tients, especially Chinese atherothrombotic infarction
patients, with low TC levels in order to improve out-
comes after stroke and reduce the disease burden.
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